FOLFIRINOX Not Better Than Gemcitabine-Cisplatin in Biliary Cancer
Abstract
Standard chemotherapy agents for advanced biliary cancer are gemcitabine and cisplatin. Recent data suggest a modest benefit for use of...
Paper Details
Title
FOLFIRINOX Not Better Than Gemcitabine-Cisplatin in Biliary Cancer
Published Date
Nov 16, 2021
Journal
Volume
2021
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History